Related Experiment Video

Updated: Aug 25, 2026

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
09:58

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Published on: January 7, 2019

Comparison of inhibin A immunoassays: recommendation for adoption of standardized reporting

Anand S Dighe1, Frances J Hayes, Javad Khosravi

  • 1Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114, USA.

Clinical Chemistry
|March 27, 2004
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Standardization of a Cytometric Bead Assay Based on Egg-Yolk Antibodies
10:23

Standardization of a Cytometric Bead Assay Based on Egg-Yolk Antibodies

Published on: May 19, 2023

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

Related Experiment Videos

Last Updated: Aug 25, 2026

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
09:58

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Published on: January 7, 2019

Standardization of a Cytometric Bead Assay Based on Egg-Yolk Antibodies
10:23

Standardization of a Cytometric Bead Assay Based on Egg-Yolk Antibodies

Published on: May 19, 2023

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.

Articles linked to this work by shared authors, journal, and citation graph.

CRISPR-Based Assay for Point-of-Care Pharmacogenetic CYP2C19 Genotyping.

ACS sensors·2026

TESTOSTERONE AND INSULIN RESISTANCE IN MEN: EVIDENCE FOR A COMPLEX BI-DIRECTIONAL RELATIONSHIP.

Transactions of the American Clinical and Climatological Association·2025

BinaxNOW vs malaria: A diagnostic showdown: Design and implementation of a verification strategy across 4 academic hospitals in an area with low malaria prevalence.

American journal of clinical pathology·2025

CRISPR-enabled point-of-care genotyping for APOL1 genetic risk assessment.

EMBO molecular medicine·2024

Discrepancy between estimated glomerular filtration rate by creatinine versus cystatin C in different patient care settings.

Clinical biochemistry·2024

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency.

The journal of allergy and clinical immunology. Global·2024

Reproducible Amyloid Typing by Data-Independent Acquisition Mass Spectrometry.

Clinical chemistry·2026

How to Establish a Reference Interval: A Practical Approach.

Clinical chemistry·2026

Current Evidence for Integrating Mass Spectrometry into Clinical M-Protein Assessment in Plasma Cell Dyscrasias.

Clinical chemistry·2026

Urinary Cell-Free DNA Fragmentomics Detects Multiple Urologic Cancers and May Reduce Unnecessary Prostate Biopsies.

Clinical chemistry·2026

Biomarker Discovery for PMM2-CDG Using Fractionated N-Glycomics Analysis.

Clinical chemistry·2026

Optimal Positive Control Assays for Methylation-Specific PCR.

Clinical chemistry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us